Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A404NG | ISIN: US68236V3024 | Ticker-Symbol:
NASDAQ
24.01.25
21:52 Uhr
1,610 US-Dollar
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
180 LIFE SCIENCES CORP Chart 1 Jahr
5-Tage-Chart
180 LIFE SCIENCES CORP 5-Tage-Chart

Aktuelle News zur 180 LIFE SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.12.24180 Life Sciences Corp. - 8-K, Current Report-
27.12.24180 Life Sciences kündigt Wertpapierangebot von 2,9 Millionen US-Dollar an1
27.12.24180 Life Sciences announces pricing of $2.9M registered direct offering1
27.12.24180 Life Sciences announces $2.9 million securities offering1
27.12.24180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules346PALO ALTO, CALIFORNIA / ACCESSWIRE / December 27, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international...
► Artikel lesen
180 LIFE SCIENCES Aktie jetzt für 0€ handeln
20.12.24180 Life Sciences Corp. - S-1/A, General form for registration of securities-
12.12.24180 Life Sciences regains compliance with Nasdaq2
12.12.24180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules417PALO ALTO, CA / ACCESSWIRE / December 12, 2024 / 180 Life Sciences Corp. ("180" or the "Company") is pleased to announce that it has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requires...
► Artikel lesen
12.12.24180 Life Sciences Corp. - 8-K, Current Report1
04.12.24180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors182PALO ALTO, CA / ACCESSWIRE / December 4, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international...
► Artikel lesen
04.12.24180 Life Sciences Corp. - 8-K, Current Report1
15.11.24180 Life Sciences files for secondary offering of common stock1
15.11.24180 Life Sciences Corp. - S-1, General form for registration of securities-
14.11.24180 Life Sciences Corp. - 10-Q, Quarterly Report-
31.10.24180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration234PALO ALTO, CA / ACCESSWIRE / October 31, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today announced the retention of Mr. Vaclav Vincalek as Senior Technology Consultant. An...
► Artikel lesen
29.10.24180 Life Sciences Corp. Sets Date for 2024 Annual Meeting2
29.10.24180 Life Sciences Corp. legt Termin für Jahreshauptversammlung 2024 fest1
29.10.24180 Life Sciences adds tech executive to board1
29.10.24180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors231PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today announced the appointment of Mr. Jay Goodman to its Board of Directors, effective...
► Artikel lesen
29.10.24180 Life Sciences Corp. - 8-K, Current Report1
Seite:  Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1